Home

Jubilant Pharmova Ltd EPS

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

EPS

₹ 35.03

Last updated on: Jul 16, 2025

Key Highlights

  • The Earning per Share of Jubilant Pharmova Ltd is ₹ 35.03 as of 16 Jul 25 .
  • The earning per share of Jubilant Pharmova Ltd changed from ₹ 0.4 to ₹ 9.71 over 8 quarters. This represents a CAGR of 392.70% .

Historical Earning per Share of Jubilant Pharmova Ltd

No data available

* All values are in

Company Fundamentals for Jubilant Pharmova Ltd

Market Cap

19,029 Cr

EPS

35.0

P/E Ratio (TTM)

34.1

P/B Ratio (TTM)

3.0

Day’s High

1204.45

Day’s Low

1178.0

DTE

0.4

ROE

8.9

52 Week High

1309.0

52 Week Low

701.4

ROCE

8.1

Market Price of Jubilant Pharmova Ltd

1M

1Y

3Y

5Y

Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
16 Jul 20251194.55
15 Jul 20251203.45
14 Jul 20251193.65
11 Jul 20251167.15
10 Jul 20251170.5
09 Jul 20251148.75
08 Jul 20251166.15
07 Jul 20251199.85
04 Jul 20251196.5
03 Jul 20251201.95

SWOT Analysis Of Jubilant Pharmova Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Jubilant Pharmova Ltd

Asset Value vs Market Value of Jubilant Pharmova Ltd

Market Value

19,029

Asset Value

Value addition

3.6 X

4,109

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Jubilant Pharmova Ltd19029
Sun Pharmaceutical Industries Ltd408091
Divis Laboratories Ltd181302
Cipla Ltd119038
Torrent Pharmaceuticals Ltd117165
Mankind Pharma Ltd108281

Historical Market Cap of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Revenue of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical EBITDA of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Net Profit of Jubilant Pharmova Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Jubilant Pharmova Ltd News Hub

Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant Biosys (J

Read more

16 Aug 24

Volumes soar at Jubilant Pharmova Ltd counter

Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Metals & Ene

Read more

01 Aug 24

Volumes soar at Jubilant Pharmova Ltd counter

Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are among the othe

Read more

09 Sept 24

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemicals Ltd are

Read more

09 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Oct 2024

PPT

July 2024

PPT

May 2024

PPT

Feb 2024

PPT

Oct 2023

PPT

July 2023

PPT

May 2023

PPT

Feb 2023

Transcript

Aug 2022

Transcript

June 2022

Transcript

Mar 2022

PPT

Jan 2022

Transcript

July 2021

Transcript

June 2021

TranscriptPPT

Jan 2021

Transcript

FAQs for EPS of Jubilant Pharmova Ltd

What is the EPS of Jubilant Pharmova Ltd stock?

The Earnings Per Share (EPS) of Jubilant Pharmova Ltd is 35.03. An EPS is the amount of net income attributed to each share of a common stock.

How is Jubilant Pharmova Ltd EPS calculated?

The EPS of Jubilant Pharmova Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Jubilant Pharmova Ltd report its EPS?

Jubilant Pharmova Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Jubilant Pharmova Ltd EPS?

Factors that influence the EPS of Jubilant Pharmova Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Jubilant Pharmova Ltd EPS growth indicate future performance?

Yes, consistent growth in Jubilant Pharmova Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions